Regulatory cells, Th1/Th2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion

Transplantation

Volumn 79, Issue 3 SUPPL., 2005, Pages

  Pirenne, Jacques ^a,b   Kitade, Hiroaki ^a   Kawai, Masaru ^a   Koshiba, Takaaki ^a   Van Damme, Boudewijn ^a   Mathieu, Chantal ^a   Waer, Mark ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CD4 ANTIGEN; CD45 ANTIGEN; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; STEROID;

ANIMAL CELL; ANIMAL MODEL; BLOOD TRANSFUSION; CHRONIC GRAFT REJECTION; CONFERENCE PAPER; DONOR SPECIFIC TRANSFUSION; DOSE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RAT; TH1 CELL; TH2 CELL;

ANIMALS; BLOOD TRANSFUSION; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; ISOANTIBODIES; TH1 CELLS; TH2 CELLS; TISSUE DONORS;

EID: 14344255907     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000153295.51565.F1     Document Type: Conference Paper

References (33)

1. Pirenne J, Van Gelder F, Kharkevitch T, et al. Tolerance of liver transplant patients to strenuous physical activity in high-altitude. Am J Transplant 2004; 4: 554.
2. Pascual M, Theruvath T, Kawai T, et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580.
3. Auchincloss H Jr. In search of the elusive holy grail: the mechanisms and prospects for achieving clinical transplantation tolerance. Am J Transplant 2001; 1: 6.
4. Morris PJ, Wood KJ, Dallman MJ. Antigen-induced tolerance to organ allografts. Ann N Y Acad Sci 1991; 636: 295.
5. Flye MW, Burton K, Mohanakumar T, et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995; 60: 1395.
6. Koshiba T, Kitade H, Van Damme B, et al. Regulatory cell-mediated operational tolerance does not protect against chronic rejection. Transplantation 2003; 76: 588.
7. Cobbold SP, Adams E, Marshall SE, et al. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CDS. Immunol Rev 1996; 149: 5.
8. Nickerson PW, Steurer W, Steiger J, Strom TB. In pursuit of the "Holy Grail": allograft tolerance. Kidney Int Suppl 1994; 44: S40.
9. Gianello P, Fishbein JM, Sachs DH. Tolerance to primarily vascularized allografts in miniature swine. Immunol Rev 1993; 133: 19.
10. Koshiba T, Giulietti A, Van Damme B, et al. Paradoxical early upregulation of intragraft Th1 cytokines is associated with graft acceptance following donor-specific blood transfusion. Transpl Int 2003; 16: 179.
11. Zand MS, Li Y, Hancock W, et al. Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts. Transplantation 2000; 70: 1378.
12. Konieczny BT, Dai Z, Elwood ET, et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 2059.
13. Bishop GA, Sun J, DeCruz DJ, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol 1996; 156: 4925.
14. Bishop GA, McCaughan GW. Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy. Liver Transpl 2001; 7: 161.
15. Sawitzki BS, Kingsley C, Karim M, et al. Interferon Gamma is Rapidly Upregulated in CD4+CD25+ Regulatory T Cells After in Vivo Antigen Stimulation. Proceedings of XIX International Congress of the Transplantation Society, Miami, USA, August 25-30, 2002.
16. Koshiba T, Van Damme B, Ji P, et al. Addition of steroids blocks the tolerogenic potential of donor-specific blood transfusion (DSBT). Transplant Proc 2001; 33: 375.
17. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
18. Waldmann H, Graca L, Cobbold S, et al. Regulatory T cells and organ transplantation. Semin Immunol 2004; 16: 119.
19. Bushell A, Karim M, Kingsley CI, Wood KJ. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation 2003; 76: 449.
20. Kawai M, Kitade H, Mathieu C, et al. Rapid presence of CD4+/CD45RC- regulatory cells in tolerated grafts: evidence for a protective role in the tolerated tissues. Am J Transplant 2004; 4(Suppl 8): 421.
21. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641.
22. Degauque N, Lair D, Braudeau C, et al. Differentiation of CD25- regulatory T cells in long term survivors rats following donor-specific transfusion (DST) in rats. Am J Transplant 2004; 4(Suppl 8): 325.
23. Furtado GC, Curotto de Lafaille MA, et al. Interleukin 2 signaling is required for CD4 (+) regulatory T cell function. J Exp Med 2002; 196: 851.
24. Kawai M, Kitade H, Mathieu C, et al. High-dose calcineurin inhibitor blocks the generation of regulatory cells, whereas low-dose promotes their development. Am J Transplant 2004; 4(Suppl 8): 262.
25. Chen N, Gao Q, Field EH. Prevention of Th1 response is critical for tolerance. Transplantation 1996; 61: 1076.
26. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
27. Le Moine A, Flamand V, Demoor FX, et al. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest 1999; 103: 1659.
28. von Herrath MG, Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003; 3: 223.
29. Zelenika D, Adams E, Humm S, et al. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 2002; 168: 1069.
30. Semiletova NV, Slomowitz SJ, Mukherjee K, et al. Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection. Am J Transplant 2004; 4(Suppl 8): 272.
31. Koksoy S, Yolcu ES, Shirwan H. Cardiac allograft tolerance established by intrathymic modulation in a rat model disparate in a single class I molecule is mediated by CD4+CD25+ treg that express FOXP3. Am J Transplant 2004; 4(Suppl 8): 422.
32. Calne RY. Prope tolerance: the future of organ transplantation-from the laboratory to the clinic. Transplantation 2004; 77: 930.
33. Pirenne J, Koshiba T, Geboes K, et al. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Transplantation 2002; 73: 966.